Enzymotec Ltd. ENZY Securities Lawsuit

Company:	Enzymotec Ltd.
Ticker Symbol:	ENZY
Class Period:	Sep-27-13 to Aug-4-14
Date Filed:	Sep-10-14
Lead Plaintiff Deadline:	Nov-9-14
Court:	District of New Jersey
Allegations:

New York, NY: A securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of those who purchased shares of Enzymotec Ltd. ("Enzymotec" or the "Company") (nasdaqgs:ENZY), during the period traceable to the Company's Initial Public Offering (IPO) on or about September 27, 2013 or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period").

The complaint charges Enzymotec and certain of its executives with violations of federal securities laws. Specifically, the complaint alleges that: (a) Enzymotec's Chinese business was subject to material and readily identifiable compliance regulations from the Chinese government; (b) Enzymotec's baby formula business in China was jeopardized and subject to increased volatility and decreased revenues; and (c) Enzymotec's joint venture with AarhusKarlshamn AB, which marketed the popular InFat product, was crumbling and subjected the Company to liability and decreased revenues.

No Class has yet been certified in the above action.



If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Enzymotec Ltd. ENZY Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Enzymotec Ltd. securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.